Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya
Health Canada, Canada’s health regulatory agency, has updated the label information for the multiple sclerosis drug Gilenya (fingolimod) to include stronger safety warnings on the risk of skin cancer and the rare brain infection progressive multifocal leukoencephalopathy (PML), which can be fatal. Gilenya, a prescription drug, is … [Read more...] about Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya
OTC Pain Killers To Bear New Safety Warnings
OTC Pain Killers Safety Warnings. The makers of over-the-counter (OTC) pain medications and fever reducers have been told by federal regulators to include new warnings on their labels about potential side effects, including stomach bleeding and liver damage.- According to a Food & Drug Administration (FDA) statement, … [Read more...] about OTC Pain Killers To Bear New Safety Warnings
